Abaloparatide for treating idiopathic or hypogonadal osteoporosis in men [ID4059]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Abaloparatide for treating osteoporosis in postmenopausal women [ID882]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Osteoporosis: risk assessment, treatment, and fragility fracture prevention (update)Status:In developmentProgramme:NICE guidelineExpected publication date: 20 January 2025